I agree that this site is using cookies. You can find further informations here.
X
Hajizadeh, Nima
41  results:
?
1

Tumor necrosis factor inhibitors and janus kinase inhibitor..:

Hajizadeh, Nima ; Heidari, Amirhossein ; Sadeghi, Sara..
PLOS ONE.  19 (2024)  2 - p. e0293433 , 2024
Link: https://doi.org/10.1371/..
 
?
2

JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe?..:

Vahabi, Seyed Mohammad ; Bahramian, Saeed ; Esmaeili, Farzad...
Cancers.  16 (2024)  5 - p. 861 , 2024
Link: https://doi.org/10.3390/..
 
?
3

New variants of COVID‐19 (XBB.1.5 and XBB.1.16, the "Arctur..:

Pourriyahi, Homa ; Hajizadeh, Nima ; Khosravi, Mina...
Immunity, Inflammation and Disease.  12 (2024)  6 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
4

Autologous adipose tissue injection in the treatment of alo..:

Sadeghi, Sara ; Ghane, Yekta ; Hajizadeh, Nima.
Journal of Cosmetic Dermatology.  , 2023
Link: https://doi.org/10.1111/..
 
?
5

PRISMA 2020 flow diagram for new systematic reviews which i..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.g001.  , 2024
Link: https://doi.org/10.1371/..
 
?
6

Characteristics of eligible studies utilizing tumor necrosi..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t002.  , 2024
Link: https://doi.org/10.1371/..
 
?
7

The list of search strategies and final results on each dat..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s003.  , 2024
Link: https://doi.org/10.1371/..
 
?
8

The list of search strategies and final results on each dat..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s003.  , 2024
Link: https://doi.org/10.1371/..
 
?
9

The quality assessment included case reports and case serie..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s006.  , 2024
Link: https://doi.org/10.1371/..
 
?
10

PRISMA 2020 checklist for reporting systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s001.  , 2024
Link: https://doi.org/10.1371/..
 
?
11

Characteristics of eligible studies with tumor necrosis fac..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t003.  , 2024
Link: https://doi.org/10.1371/..
 
?
12

Characteristics of eligible studies utilizing tumor necrosi..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t002.  , 2024
Link: https://doi.org/10.1371/..
 
?
13

The quality assessment included observational cohort and cr..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s004.  , 2024
Link: https://doi.org/10.1371/..
 
?
14

PRISMA 2020 checklist for reporting systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s001.  , 2024
Link: https://doi.org/10.1371/..
 
?
15

The quality assessment included before-after studies with n..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s005.  , 2024
Link: https://doi.org/10.1371/..
 
1-15